Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic cytokine circuits that drive T cells into immune-excluded tumors
Greg M. Allen, Nicholas Frankel, Nishith R. Reddy, et al.
Science (2022) Vol. 378, Iss. 6625
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

CAR T therapy beyond cancer: the evolution of a living drug
Daniel Baker, Zoltàn Arany, Joseph A. Baur, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 707-715
Closed Access | Times Cited: 227
From bench to bedside: the history and progress of CAR T cell therapy
Aroshi Mitra, Amrita Barua, Luping Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 175
Cancer immunotherapies: advances and bottlenecks
Rui Rui, Liqun Zhou, Shiming He
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 165
Opportunities for Treg cell therapy for the treatment of human disease
Jeffrey A. Bluestone, Brent S. McKenzie, Joshua Beilke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
Lin Tang, Sheng Pan, Xuyong Wei, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3146-3162
Open Access | Times Cited: 43
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
Sebastian Klobuch, Tom Seijkens, Ton N. Schumacher, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 173-184
Closed Access | Times Cited: 38
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control
Li Lu, Mingqi Xie, Bo Yang, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 19
CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)
Dahua Sun, Xiang Shi, Sanyan Li, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 17
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond
Sebastian Bittner, Thomas Hehlgans, Markus Feuerer
Trends in Immunology (2023) Vol. 44, Iss. 6, pp. 468-483
Open Access | Times Cited: 36
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
Brittany Dewdney, Misty R. Jenkins, Sarah A. Best, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 25
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
Gang Jin, Yanyan Liu, Lixia Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1059-1072
Closed Access | Times Cited: 14
Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells
Dong Hu, Ruyue Yang, Guidan Wang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2773-2791
Open Access | Times Cited: 10
CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Kewen Qian, Guangyao Li, Shuyi Zhang, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 9
Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer
Ye Li, Katayoun Rezvani, Hind Rafei
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 217-235
Open Access | Times Cited: 21
Harnessing the power of artificial intelligence to advance cell therapy
Sara Capponi, Kyle G. Daniels
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 147-165
Open Access | Times Cited: 20
Nanomaterials Boost CAR‐T Therapy for Solid Tumors
Jun Long, Yian Wang, Xianjie Jiang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 7
Engineering programmable material-to-cell pathways via synthetic notch receptors to spatially control differentiation in multicellular constructs
Mher Garibyan, Tyler Hoffman, Thijs Makaske, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
CAR-T cell combination therapies in hematologic malignancies
Delian Zhou, Xiaojian Zhu, Yi Xiao
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Synthetic macromolecular switches for precision control of therapeutic cell functions
Ana P. Teixeira, Martin Fussenegger
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 7
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
Nishith R. Reddy, Hasna Maachi, Yini Xiao, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 6
Visualizing cell–cell communication using synthetic notch activated MRI
TianDuo Wang, Yuanxin Chen, Nivin N. Nyström, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top